| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blood Matters
|
Oyekan, Fiyinfolu Deborah
|
|
|
9 |
7 |
p. 600
|
artikel
|
| 2 |
Chronic Boom
|
Moody, Joe
|
|
|
9 |
7 |
p. 599
|
artikel
|
| 3 |
Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis
|
Wankhede, Durgesh
|
|
|
9 |
7 |
p. 609-619
|
artikel
|
| 4 |
Correction to Lancet Gastroenterol Hepatol 2024; 9: 34–44
|
|
|
|
9 |
7 |
p. e10
|
artikel
|
| 5 |
Correction to Lancet Gastroenterol Hepatol 2024; 9: 620–31
|
|
|
|
9 |
7 |
p. e10
|
artikel
|
| 6 |
Direct-to-consumer microbiome testing needs regulation
|
The Lancet Gastroenterology & Hepatology,
|
|
|
9 |
7 |
p. 583
|
artikel
|
| 7 |
Duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy in Ontario, Canada: a population-based cohort study
|
Ruco, Arlinda
|
|
|
9 |
7 |
p. 601-608
|
artikel
|
| 8 |
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
|
Ovchinsky, Nadia
|
|
|
9 |
7 |
p. 632-645
|
artikel
|
| 9 |
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|
Miethke, Alexander G
|
|
|
9 |
7 |
p. 620-631
|
artikel
|
| 10 |
Negative screening colonoscopy and long-term colorectal cancer risk—is it time to extend the screening interval?
|
IJspeert, J E G
|
|
|
9 |
7 |
p. 584-585
|
artikel
|
| 11 |
Pathophysiology and therapeutic options for cirrhotic portal hypertension
|
Guixé-Muntet, Sergi
|
|
|
9 |
7 |
p. 646-663
|
artikel
|
| 12 |
Providing trauma-informed care for all in gastroenterology
|
Jagielski, Christina H
|
|
|
9 |
7 |
p. 587-588
|
artikel
|
| 13 |
Research in Brief
|
Baker, Holly
|
|
|
9 |
7 |
p. 597
|
artikel
|
| 14 |
Resmetirom for MASH-related cirrhosis
|
Feng, Gong
|
|
|
9 |
7 |
p. 594
|
artikel
|
| 15 |
Rethinking colorectal cancer prognosis: beyond microsatellite status
|
Fenocchio, Elisabetta
|
|
|
9 |
7 |
p. 585-586
|
artikel
|
| 16 |
Targeting the EGFR signalling pathway in metastatic colorectal cancer
|
Napolitano, Stefania
|
|
|
9 |
7 |
p. 664-676
|
artikel
|
| 17 |
The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa
|
Wang, Jian
|
|
|
9 |
7 |
p. 589
|
artikel
|
| 18 |
The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa – Authors' reply
|
Minier, Nicolas
|
|
|
9 |
7 |
p. 589-590
|
artikel
|
| 19 |
The Mediterranean diet for gastrointestinal conditions—premature or panacea?
|
Staudacher, Heidi M
|
|
|
9 |
7 |
p. 598
|
artikel
|
| 20 |
The role of ERAS in robotic pancreaticoduodenectomy
|
Moris, Dimitrios
|
|
|
9 |
7 |
p. 594-595
|
artikel
|
| 21 |
The role of ERAS in robotic pancreaticoduodenectomy – Authors' reply
|
Liu, Qu
|
|
|
9 |
7 |
p. 595-596
|
artikel
|
| 22 |
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
|
Chen, Rirong
|
|
|
9 |
7 |
p. 592
|
artikel
|
| 23 |
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
|
Satsangi, Jack
|
|
|
9 |
7 |
p. 591-592
|
artikel
|
| 24 |
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
|
Borkar, Vinay
|
|
|
9 |
7 |
p. 591
|
artikel
|
| 25 |
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
|
Bourgonje, Arno R
|
|
|
9 |
7 |
p. 590-591
|
artikel
|
| 26 |
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial – Authors' reply
|
Noor, Nurulamin M
|
|
|
9 |
7 |
p. 592-594
|
artikel
|
Tijdschrift beschrijving